Compounds and methods for assessment of microsatellite...

Chemistry: molecular biology and microbiology – Micro-organism – tissue cell culture or enzyme using process... – Preparing compound containing saccharide radical

Reexamination Certificate

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C435S006120, C536S023100, C536S024300, C536S024330

Reexamination Certificate

active

07662595

ABSTRACT:
The present invention provides a method for assessment of the Microsatellite Instability (MSI) status of medically relevant conditions associated with MSI phenotype such as e.g. neoplastic lesions. The method is based on the analysis of a monomorphic T25 (CAT25) mononucleotide repeat located in the 3′-UTR of the Caspase 2 (CASP2) gene. Based on the determination of the length of the named mononucleotide repeat the presence or absence of MSI may be assessed. Determination of the length is performed in a single PCR procedure. Alternatively an enhanced assessment could be performed by combining the CAT25 marker with further markers such as BAT25 and BAT26 in a single multiplex PCR process.

REFERENCES:
patent: 0 640 828 (1995-03-01), None
patent: 1 340 819 (2003-09-01), None
patent: WO 01/29262 (2001-04-01), None
patent: WO 02/10449 (2002-02-01), None
Lucentini, J. ‘Gene Association Studies Typically Wrong’ The Scientist (Dec 20, 2004), p. 20.
Juppner H. Bone (Aug 1995) vol. 17, No. 2, Supplement, pp. 39S-42S.
Hegele R.A. Arterioscler Thromb Vasc Biol (2002) vol. 22, pp. 1058-1061.
Siah S.P. et al. Breast Cancer Research and Treatment (2000) vol. 60, p. 135-142.
Planck M. et al. Cancer Genetics and Cytogenetics (2002) vol. 134, p. 46-54.
Banerjea A et al: “Colorectal cancers with mononucleotide microsatellite instability can be identified using microfabricated chip technology”, Analytical Biochemistry, Academic Press, San Diego, CA, US, vol. 322, No. 1, Nov. 1, 2003, pp. 130-133, XP004458931.
Thorstensen L et al: “WNT1 inducible signaling pathway protein 3, WISP-3, a novel target gene in colorectal carcinomas with microsatellite instability”, Gastroenterology, vol. 121, No. 6, Dec. 2001, pp. 1275-1280, XP002337304.
Sutter C et al: “Molecular screening of potential HNPCC patients using a multiplex microsatellite PCR system”, Molecular and Cellular Probes, Academic Press, London, GB, vol. 13, No. 2, Apr. 1999, pp. 157-165, XP004450201.
Logette Emmanuelle et al: “The human caspase-2 gene: Alternative promoters, pre-mRNA splicing and AUG usage direct isoform-specific expression”, Oncogene, vol. 22, No. 6, Feb. 13, 2003, pp. 935-946, XP002337305.
Database Geneseq [Online], Jul. 15, 2002, “Human spliced transcript detection oligonucleotide SEQ ID No: 8521”, XP002337351, EBI accession No. GSN: ABN35773.
“ABI PRISM 310 Genetic Analyser—The measure of enabling technology”, Product Bulletin, [Online] 2002, pp. 1-6, XP002337306, http://docs.appliedbiosystems.com/pebiodocs/00105575.pdf.>
“ABI PRISM 3100 Genetic analyser”, Product Brochure from Applied Biosystems, [Online] 2001, pp. 1-8, XP002337307, http://docs.appliedbiosystems.com/pebiodocs/00103320.pdf>.
Database Geneseq [Online], Jul. 2, 2002, “Human gene specific PCR primer #866”, XP002337352, EBI accession no. GSN: ABK66778.
Database Geneseq [Online], Jul. 26, 2002, “Human caspase2 antisense inhibitor oligonucleotide #36”, XP002337353, EBI accession No. GSN: ABN74858.
Database Geneseq [Online], Nov. 20, 2003, “Human MDZ7 scanning oligonucleotide SEQ ID 5326”, XP002337354, EBI accession No. GSN: ADB04340.
Database Genbank [Online], Dec. 17, 2003, “Homo sapienscaspase2, apoptosis-related cysteine protease (neural precursor cell expressed, developmentally down-regulated 2) (CASP2), transcript variant 1, mRNA”, XP002373466, NCBI accession No. NM—032982.2.
Database Genbank [Online], Oct. 5, 2003, “Homo sapienscaspase2, apoptosis-related cysteine protease (neural precursor cell expressed, developmentally down-regulated 2) (CASP2), transcript variant 1, mRNA”, XP002337350, NCBI accession No. NM—032982.1.
Banerjea Ayan et al: “Colorectal cancers with microsatellite instability display mRNA expression signatures characteristic of increased immunogenicity”, Molecular Cancer [Electronic resource], vol. 3, No. 1, Aug. 6, 2004, pp. 21(1)-21(11), XP002337308.
Takeuchi Seisho et al: “Frameshift mutations in caspase-5 and other target genes in leukemia and lymphoma cell lines having microsatellite instability”, Leukemia Research, vol. 27, No. 4, Apr. 2003, pp. 359-361, XP002337320.
Findeisen Peter et al: “T-25 repeat in the 3 'untranslated region of the CASP2 gene: A sensitive and specific marker for microsatellite instability in colorectal cancer”, Cancer Research, vol. 65, No. 18, Sep. 2005, pp. 8072-8078, XP002373166.
International Search Report for PCT/EP2005/055375, mailed Apr. 18, 2006.
International Preliminary Report on Patentability for PCT/EP2005/055375, issued Apr. 24, 2007.

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Compounds and methods for assessment of microsatellite... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Compounds and methods for assessment of microsatellite..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Compounds and methods for assessment of microsatellite... will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-4190506

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.